InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-07 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| NET REVENUE | $727.3M+10.1% | $660.6M+11.6% | $591.6M+16.1% | $509.7M | — |
| COST OF REVENUE | $413.0M+11.5% | $370.5M+517.6% | $60.0M-0.2% | $60.1M+13.6% | $52.9M |
| GROSS MARGIN | $314.3M+8.3% | $290.1M+18.6% | $244.6M | — | — |
| General and administrative | $273.3M+5.2% | $259.7M+6.8% | $243.1M-0.1% | $243.4M+9.9% | $221.3M |
| Research and development | $37.1M+19.0% | $31.2M+14.1% | $27.3M-9.9% | $30.3M+38.6% | $21.9M |
| Sales and marketing | $92.0M+8.7% | $84.7M+19.5% | $70.8M+5.2% | $67.3M+7.6% | $62.6M |
| Restructuring charges | $0-100.0% | $6.7M-40.0% | $11.1M+145.5% | $4.5M | $0 |
| Impairment charges (Note 3 and Note 7) | $27.8M | $0 | $0 | — | — |
| Total operating expenses | $430.2M+12.6% | $382.2M+8.5% | $352.3M+2.0% | $345.5M+13.0% | $305.8M |
| LOSS FROM OPERATIONS | -$115.9M-25.8% | -$92.1M+14.5% | -$107.7M+31.6% | -$157.6M-32.7% | -$118.8M |
| Interest income | -$9.1M+50.8% | -$18.4M-9.0% | -$16.9M-178.2% | -$6.1M-93.6% | -$3.1M |
| Interest expense | $3.8M-43.3% | $6.6M-4.2% | $6.9M-8.9% | $7.6M-7.8% | $8.2M |
| Other (income) expense, net | -$296K-178.1% | $379K+158.9% | -$644K | — | — |
| Loss before taxes | -$110.3M-36.7% | -$80.7M+16.9% | -$97.1M+39.1% | -$159.3M-957.0% | -$15.1M |
| Income tax benefit | -$2.2M-15.1% | -$1.9M+78.7% | -$9.1M+39.5% | -$15.1M-124.3% | -$6.7M |
| NET LOSS | -$108.0M-37.2% | -$78.7M+10.5% | -$88.0M+39.0% | -$144.3M-1628.2% | -$8.3M |
| Basic (in dollars per share) | -$840-35.5% | -$620+11.4% | -$700+39.7% | -$1K-1557.1% | -$70 |
| Diluted (in dollars per share) | -$840-35.5% | -$620+11.4% | -$700+39.7% | -$1K-1557.1% | -$70 |
| Basic (in shares) | $128.1M+1.1% | $126.7M+0.9% | $125.5M+1.0% | $124.2M+3.5% | $120.0M |
| Diluted (in shares) | $128.1M+1.1% | $126.7M+0.9% | $125.5M+1.0% | $124.2M+3.5% | $120.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
NeoGenomics Shares Jump on Earnings and Analyst Upgrades
NeoGenomics signals $797M-$803M 2026 revenue outlook following PanTracer Liquid MolDX approval
NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call Transcript
NeoGenomics Inc (NEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...